Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Schwab Fundamental US Large Company Index ETF
FNDX
$27B
| $150K | ﹤0.01% |
+8,229
| New | +$149K |
|
|
VRN
3627
DELISTED
Veren
VRN
| $150K | ﹤0.01% |
33,082
+14,791
| +81% | +$62K |
|
|
HMTV
3628
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $150K | ﹤0.01% |
12,740
-13,110
| -51% | -$162K |
|
3629
ENI
E
$79B
| $149K | ﹤0.01% |
6,100
-5,696
| -48% | -$142K |
|
3630
Oak Valley Bancorp
OVLY
$283M
| $149K | ﹤0.01% |
8,206
-3,988
| -33% | -$71K |
|
|
SOLO
3631
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $149K | ﹤0.01% |
34,808
+17,733
| +104% | +$72.9K |
|
3632
Camtek
CAMT
$6.52B
| $148K | ﹤0.01% |
3,933
+945
| +32% | +$32.1K |
|
3633
PUT
Duke Energy
DUK
$96.9B
| $148K | ﹤0.01% |
1,500
| – | – |
|
3634
iShares US Regional Banks ETF
IAT
$682M
| $148K | ﹤0.01% |
+2,578
| New | +$153K |
|
|
INFN
3635
CALL
DELISTED
Infinera Corporation Common Stock
INFN
| $148K | ﹤0.01% |
+14,500
| New | +$141K |
|
|
SBBP
3636
DELISTED
Strongbridge Biopharma plc.
SBBP
| $148K | ﹤0.01% |
49,839
+13,032
| +35% | +$34.4K |
|
3637
PUT
HSBC
HSBC
$370B
| $147K | ﹤0.01% |
5,100
| – | – |
|
|
LOVE
3638
DELISTED
LoveSac
LOVE
| $147K | ﹤0.01% |
1,842
-6,889
| -79% | -$513K |
|
|
CIO
3639
DELISTED
City Office REIT
CIO
| $146K | ﹤0.01% |
11,782
-30,732
| -72% | -$356K |
|
3640
PUT
Devon Energy
DVN
$51.4B
| $146K | ﹤0.01% |
5,000
| – | – |
|
|
PHD
3641
DELISTED
Pioneer Floating Rate Fund
PHD
| $146K | ﹤0.01% |
12,418
| – | – |
|
|
RUBY
3642
DELISTED
Rubius Therapeutics, Inc
RUBY
| $146K | ﹤0.01% |
6,008
-24,461
| -80% | -$612K |
|
|
IVC
3643
DELISTED
Invacare Corporation
IVC
| $146K | ﹤0.01% |
18,142
-24,510
| -57% | -$204K |
|
|
CTT
3644
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $146K | ﹤0.01% |
12,379
-58,772
| -83% | -$683K |
|
3645
Atossa Therapeutics
ATOS
$21.6M
| $145K | ﹤0.01% |
1,538
-2,842
| -65% | -$150K |
|
3646
Gyre Therapeutics
GYRE
$681M
| $145K | ﹤0.01% |
4,484
-2,961
| -40% | -$102K |
|
3647
Barnes & Noble Education
BNED
$447M
| $144K | ﹤0.01% |
201
+24
| +14% | +$19.4K |
|
3648
Cineverse
CNVS
$58.5M
| $144K | ﹤0.01% |
+5,597
| New | +$154K |
|
3649
Commercial Vehicle Group
CVGI
$156M
| $144K | ﹤0.01% |
13,459
-22,126
| -62% | -$245K |
|
3650
Powell Industries
POWL
$8B
| $144K | ﹤0.01% |
13,965
-19,479
| -58% | -$224K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.